Janssen GI patient database includes 300,000 names; Propulsid QuickSolv launch supported by targeted mailing.
JANSSEN GASTROINTESTINAL PATIENT DATABASE INCLUDES 300,000 NAMES, Janssen Gastroenterology and Mycology Group Director Joseph Sanger told the PharMillenium conference sponsored by Industry Events International Jan. 29 in Stuart, Fla. Janssen has gathered data on patients who have called a toll-free number in response to its advertisements for gastroesophageal reflux disease over the past two-and-a-half years, Sanger said. Patients are segmented into: "satisfied and unsatisfied; Rx users and OTC users; [and] users of our products and competitors' products."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth